TPEX/6617 (TPEX/6617)

Taipei Exchange: TPEX/6617 · TWD

NT$114

-2.00 (-1.7%)· Recorded snapshot

Market cap	13.7B
Revenue (ttm)	42.2M
Net income (ttm)	-164.5M
EPS (ttm)	-NT$1.35
Shares out	121.1M
Volume	245,544
Beta	0.31

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 42.2M
Net income (ttm): -164.5M
EPS (ttm): -NT$1.35
Market cap: 13.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-7.4

P25 n/aP50 n/aP75 n/a

ROIC-6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TPEX/6617 indicators

Market & fundamental data

Available fields

173

Groups with data

Currency

TWD

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	TWD
Country	Cayman Islands
Country code	TW
Earnings date	2026-11-13
Enterprise value	TWD 12.4B
Exchange	Taipei Exchange
Financial currency	TWD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2014
Industry	Biotechnology
Is primary listing	Yes
ISIN number	KYG409471060
Last earnings date	2025-11-21
Last refreshed	2026-10-28
Market cap	TWD 13.7B
Next earnings date	2026-11-13
Price	TWD 113.50
Price currency	TWD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	tpex/6617
Website	https://www.gongwinbiopharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-1.19%
EV/Sales	293.32x
FCF / EV yield	-1.6%
FCF yield	-1.44%
Industry forward P/E	174.47x
P/B ratio	5.91x
P/S ratio	325.58x
Price / tangible book value	5.91x
Sector forward P/E	28.08x
Sector P/E	83.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	63.09%
Operating margin	-571.17%
Pretax margin	-417.11%
ROA	-5.65%
ROA (5Y)	-6.33%
ROCE	-9.91%
ROE	-7.36%
ROE (5Y)	-10.62%
ROIC	-5.98%
Tax / revenue	0.12%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	144.86%
Gross profit growth (Q)	-7.26%
Gross profit growth 5Y	102.31%
Net income growth years	0
Revenue growth	22.49%
Revenue growth (Q)	45.05%
Revenue growth (QoQ)	33.99%
Revenue growth 3Y	164.11%
Revenue growth 5Y	119.27%
Revenue growth quarters	2
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	TWD -2.4M
Depreciation and amortization	TWD 8.6M
EBIT	TWD -241.2M
EBITDA	TWD -232.5M
EPS	TWD -1.35
FCF per share	TWD -1.64
Financing cash flow	TWD -90.5M
Free cash flow	TWD -198.3M
Gross profit	TWD 26.6M
Income taxes	TWD 49,000
Investing cash flow	TWD 366M
Net borrowing	TWD 26.8M
Net cash flow	TWD 178M
Net income	TWD -164.5M
Operating income	TWD -241.2M
Revenue	TWD 42.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	18.8
Book value per share	TWD 19.21
Debt / equity	0.06
Interest coverage	-59.05
Long-term assets	TWD 922M
Long-term liabilities	TWD 107.2M
Net cash (debt)	TWD 1.4B
Net cash / market cap	9.9%
Net cash growth	-8.83%
Net debt / equity	-0.59
Piotroski F-Score	2
Property, plant and equipment	TWD 318.7M
Shareholders' equity	TWD 2.3B
Tangible book value	TWD 2.3B
Tangible book value per share	TWD 19.20
Total assets	TWD 2.6B
Total cash	TWD 1.5B
Total debt	TWD 149.9M
Total liabilities	TWD 317.3M
WACC	5.9%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.02
Current assets	TWD 1.7B
Current liabilities	TWD 210.1M
Current ratio	8.19
Inventory turnover	3.84
Net working capital	TWD 141.4M
Quick ratio	7.29
Working capital	TWD 1.5B
Working capital turnover	0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.82%
Shareholder yield	2.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	TWD 91.12
1D price change	-1.73%
1M price change	-15.33%
1M total return	-15.33%
1Y price change	21.85%
1Y return CAGR	21.87%
1Y total return	21.85%
20-day SMA	TWD 122.85
200-day SMA	TWD 87.96
3M price change	37.93%
3M total return	37.93%
3Y price change	-36.96%
3Y return CAGR	-14.25%
3Y total return	-36.96%
50-day SMA	TWD 122.52
50-day SMA vs 200-day SMA	50over200
52-week high	TWD 149.00
52-week high date	2026-09-17
52-week low	TWD 58.30
52-week low date	2026-04-23
5Y price change	-45.41%
5Y return CAGR	-11.19%
5Y total return	-44.76%
6M price change	62.92%
6M total return	62.92%
All-time high	TWD 457.00
All-time high date	2022-08-17
All-time low	TWD 47.50
All-time low date	2017-07-19
Average true range (ATR)	TWD 6.19
Average volume	535.7K
Beta (1Y)	0.06
Beta (2Y)	0.4
Beta (5Y)	0.31
Change from 52-week high	-23.83%
Change from 52-week low	94.68%
Change from all-time high	-74.62%
Change from all-time low	144.21%
Change from open	-2.16%
Day's gap	0.43%
Dollar volume	TWD 27.9M
High price	TWD 118.00
Low price	TWD 113.00
Monthly RSI	51.1
Open price	TWD 116.00
Position in 52-week range	10%
Previous close	TWD 115.50
Price vs 150-day SMA	27.31%
Price vs 20-day SMA	-5.58%
Price vs 200-day SMA	31.87%
Price vs 50-day SMA	-5.32%
Relative volume	0.46
RSI	43.56
Sharpe ratio	0.54
Sharpe ratio (3Y)	-0.11
Sharpe ratio (5Y)	-0.07
Sortino ratio	1.06
Sortino ratio (3Y)	-0.05
Sortino ratio (5Y)	0.02
Volume	245.5K
Weekly RSI	57.05
YTD price change	34.73%
YTD total return	34.73%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	53.6M
Shares change (QoQ)	-0.97%
Shares change (YoY)	-2.82%
Shares held by insiders	24.59%
Shares held by institutions	0.04%
Shares outstanding	121.1M

Deeper analysis on TPEX/6617

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TPEX/6617 report

Is a complete TPEX/6617 research report available?

No complete published report is available for tpex/6617 (TPEX/6617) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TPEX/6617 (TPEX/6617)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/6617

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/6617 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TPEX/6617

Frequently asked questions